Imunon (IMNN): Three Filers Report 2,000 Shares Each (0.01%)

Rhea-AI Filing Summary

Imunon, Inc. received a Schedule 13G/A reporting that three related reporting persons — Ayrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) and individual Waqas Khatri — each beneficially own 2,000 shares of the issuer's common stock that are issuable on the exercise of certain warrants and conversion of certain convertible notes. The filing states these holdings represent 0.01% each based on 17,541,732 shares outstanding cited in the issuer's registration statement prior to a July 2025 reverse stock split.

The filing notes the warrants are subject to a 9.99% beneficial ownership blocker and includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Positive

• Clear, specific disclosure of the number of issuable shares (2,000) and the pre-split outstanding share base (17,541,732)
• Certification that the securities are held in the ordinary course and not to change or influence control
• Beneficial ownership blocker (9.99%) limits near-term accumulation risk from the warrants

Negative

• None.

Insights

Financial Analyst

TL;DR: Small, non-control positions; limited market impact; potential dilution exists but immaterial at reported scale.

The three reporting persons each hold rights to 2,000 shares, equivalent to 0.01% of the cited 17,541,732 outstanding shares (pre-reverse-split basis). These are issuable on exercise/conversion of warrants and notes, so they represent potential dilution rather than current voting stock. The presence of a 9.99% beneficial ownership blocker limits immediate accumulation risk. Overall, at this scale the holdings are immaterial to market capitalization or governance and are unlikely to move pricing or influence strategic decisions.

Corporate Governance Expert

TL;DR: Filing shows compliance and clarifies no intent to influence control; governance risk is minimal.

The disclosure identifies the investment manager, fund vehicle and the individual managing member as reporting persons and states the securities are held in the ordinary course of business with no intent to affect control. The filing documents sole voting and dispositive power over the reported 2,000 issuable shares for each filer and notes the 9.99% ownership blocker on the warrant-related shares. From a governance perspective this is a routine transparency filing with no apparent control implications.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IMNN shares do the reporting persons beneficially own?

Each reporting person reports beneficial ownership of 2,000 shares issuable on the exercise of warrants and conversion of convertible notes.

What percentage of IMNN does 2,000 shares represent?

0.01% of the 17,541,732 shares outstanding referenced in the filing (pre-reverse-split basis).

Are the reported IMNN shares currently outstanding or issuable?

The reported shares are issuable upon exercise of certain warrants and conversion of certain convertible notes, not currently counted as outstanding shares held by the filers.

Is there any ownership limit or blocker on the reported shares?

Yes. The filing states the shares related to the exercise of the warrants are subject to a 9.99% beneficial ownership blocker.

Did the filers state intent to influence control of Imunon (IMNN)?

No. The filers certified the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/13/2025 - 06:29 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Imunon, Inc.

(Name of Issuer)

Common stock, par value $0.01 per share

(Title of Class of Securities)

15117N602

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 15117N602

1

Names of Reporting Persons

Ayrton Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 15117N602

1

Names of Reporting Persons

Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. 15117N602

1

Names of Reporting Persons

Waqas Khatri

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Imunon, Inc.
(b)	Address of issuer's principal executive offices: 997 Lenox Drive, Suite 100, Lawrenceville, NEW JERSEY, 08648.
Item 2.
(a)	Name of person filing: (i) Ayrton Capital LLC; (ii) Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B; and (iii) Waqas Khatri
(b)	Address or principal business office or, if none, residence: (i) Ayrton Capital LLC, 55 Post Rd West, 2nd Floor Westport, CT 06880; (ii) Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B, Suite #7 Grand Pavilion Commercial Centre, 802 West Bay Road, Grand Cayman, P.O. Box 10250, Cayman Islands; and (iii) Waqas Khatri 55 Post Rd West, 2nd Floor Westport, CT 06880
(c)	Citizenship: (i) Ayrton Capital LLC: United States; (ii) Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B: Cayman Islands; and (iii) Waqas Khatri: United States
(d)	Title of class of securities: Common stock, par value $0.01 per share
(e)	CUSIP No.: 15117N602
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Ayrton Capital LLC: 2,000; (ii) Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B: 2,000; and (iii) Waqas Khatri: 2,000. Represents 2,000 shares of Common Stock issuable on the exercise of certain warrants (the "Warrants") and conversion of certain convertible notes (the "Notes") held by the Reporting Persons. The issuable shares of Common Stock related to the exercise of the Warrants is subject to a 9.99% beneficial ownership blocker. The shares reported herein represent Common Stock of Imunon, Inc. (the "Issuer") held by Alto Opportunity Master Fund, SPC- Segregated Master Portfolio B, a Cayman Islands exempted company (the "Fund"). The Fund is a private investment vehicle for which Ayrton Capital LLC, a Delaware limited liability company (the "Investment Manager"), serves as the investment manager. Waqas Khatri serves as the managing member of the Investment Manager (all of the foregoing, collectively, the "Reporting Persons").
(b)	Percent of class: The percentages below are based on 17,541,732 shares of Common Stock of the Issuer that were outstanding as of May 16, 2025 held by the Reporting Persons. The amount of shares outstanding was based upon a statement in the Issuer's Form S-1/A filed on May 19, 2025. For the sake of clarity, the holdings of the Reporting Persons reported herein are as of June 30, 2025, and are based on reported amounts prior to the Issuer's reverse stock split in July 2025. (i) Ayrton Capital LLC: 0.01%; (ii) Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B: 0.01%; and (iii) Waqas Khatri: 0.01%.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: (i) Ayrton Capital LLC: 2,000; (ii) Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B: 2,000; and (iii) Waqas Khatri: 2,000
	(ii) Shared power to vote or to direct the vote: (i) Ayrton Capital LLC: 0; (ii) Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B: 0; and (iii) Waqas Khatri: 0
	(iii) Sole power to dispose or to direct the disposition of: (i) Ayrton Capital LLC: 2,000; Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B: 2,000; Waqas Khatri: 2,000
	(iv) Shared power to dispose or to direct the disposition of: (i) Ayrton Capital LLC: 0; (ii) Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B: 0; (iii) Waqas Khatri: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Ayrton Capital LLC

Signature:	/s/ Waqas Khatri
Name/Title:	Waqas Khatri / Managing Member
Date:	08/13/2025

Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B

Signature:	/s/ Waqas Khatri
Name/Title:	Waqas Khatri / Director
Date:	08/13/2025

Waqas Khatri

Signature:	/s/ Waqas Khatri
Name/Title:	Waqas Khatri
Date:	08/13/2025